Summary
Quest Diagnostics Inc. (DGX) filed an 8-K on April 19, 2018, to announce its first-quarter 2018 financial results. The primary purpose of this filing is to publicly disclose the company's performance for the period ending March 31, 2018, as detailed in an accompanying press release. Investors should review this release for key financial metrics and operational updates that could impact the company's valuation and future outlook.
Key Highlights
- 1Quest Diagnostics announced its financial results for the quarter ended March 31, 2018.
- 2The company issued a press release on April 19, 2018, to communicate these results.
- 3This 8-K filing incorporates the press release by reference, making it an accessible source of information for investors.
- 4The filing specifically falls under Item 2.02 (Results of Operations and Financial Condition).
- 5Item 9.01 (Financial Statements and Exhibits) lists the press release as Exhibit 99.1.
- 6Investors can access the detailed financial performance and any accompanying commentary in the referenced press release.
Frequently Asked Questions
The main purpose of this 8-K filing is to publicly announce and provide access to Quest Diagnostics' financial results for the first quarter ended March 31, 2018, through an attached press release.
The detailed financial information is located in the press release dated April 19, 2017 (note: there might be a typo in the filing content, it should likely be 2018), which is included as Exhibit 99.1 and incorporated by reference into the 8-K.
This report, under Item 2.02, primarily covers Quest Diagnostics' Results of Operations and Financial Condition for the quarter ended March 31, 2018. Specific details would be found within the referenced press release.